Publications by authors named "Hannah Cheeseman"

Claim this Profile
H
HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trial.
Emma I M M Reiss, Karlijn van der Straten, Laura T M Graus, Marloes Grobben, Kilian E Vlaming, Hannah M Cheeseman

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals.
Jonathan Kitonsa, Jennifer Serwanga, Hannah M Cheeseman, Andrew Abaasa, Jane Frances Lunkuse

Vaccines (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth.
Katrina M Pollock, Hannah M Cheeseman, Leon R McFarlane, Suzanne Day, Monica Tolazzi

EBioMedicine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial.
Katrina M Pollock, Álvaro H Borges, Hannah M Cheeseman, Ida Rosenkrands, Kirstine L Schmidt

Lancet Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccination.
Ida Rosenkrands, Anja W Olsen, Sara Knudsen, Nida Dehari, Helene Bæk Juel, Hannah M Cheeseman

EBioMedicine· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice.
Anja W Olsen, Ida Rosenkrands, Christina S Jacobsen, Hannah M Cheeseman, Max P Kristiansen

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens.
Gregory M Martin, Rebecca A Russell, Philip Mundsperger, Scarlett Harris, Lu Jovanoska, Hannah Cheeseman

NPJ Vaccines· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.
Alex J Szubert, Katrina M Pollock, Hannah M Cheeseman, Jasmini Alagaratnam, Henry Bern

EClinicalMedicine· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines.
Tamara Elliott, Hannah M Cheeseman, Abbey B Evans, Suzanne Day, Leon R McFarlane

PLoS Pathog· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens.
Suzanne Day, Charandeep Kaur, Hannah M Cheeseman, Emily de Groot, Leon R McFarlane

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial.
Katrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, Vincenzo Libri, Marta Boffito

EClinicalMedicine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicolor Flow Cytometry and High-Dimensional Data Analysis to Probe Complex Questions in Vaccinology.
Megan E Cole, Yanping Guo, Hannah M Cheeseman, Katrina M Pollock

Methods Mol Biol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study.
Maya Moshe, Anna Daunt, Barnaby Flower, Bryony Simmons, Jonathan C Brown, Hannah Cheeseman

BMJ· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1.
Katja Klein, Immaculate Nankya, Gabrielle Nickel, Annette N Ratcliff, Adam A J Meadows, Hannah M Cheeseman

J Virol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey.
Barnaby Flower, Jonathan C Brown, Bryony Simmons, Maya Moshe, Rebecca Frise, Hannah M Cheeseman

Thorax· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.
Sonya Abraham, Helene B Juel, Peter Bang, Hannah M Cheeseman, Rebecca B Dohn

Lancet Infect Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine.
Hannah Mary Cheeseman, Suzanne Day, Leon Robert McFarlane, Sue Fleck, Aleisha Miller

Hum Gene Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission.
Hannah M Cheeseman, Ann M Carias, Abbey B Evans, Natalia J Olejniczak, Paul Ziprin

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions.
Anush Arakelyan, Wendy Fitzgerald, Deborah F King, Paul Rogers, Hannah M Cheeseman

Sci Rep· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
Hannah M Cheeseman, Natalia J Olejniczak, Paul M Rogers, Abbey B Evans, Deborah F L King

J Virol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
Jakub Kopycinski, Peter Hayes, Ambreen Ashraf, Hannah Cheeseman, Francesco Lala

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.
Peter Hayes, Jill Gilmour, Andrea von Lieven, Dilbinder Gill, Lorna Clark, Hannah Cheeseman

Clin Vaccine Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
Michael C Keefer, Jill Gilmour, Peter Hayes, Dilbinder Gill, Jakub Kopycinski, Hannah Cheeseman

PLoS One· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4β7-binding V2 loop of HIV gp120 in healthy volunteers.
Jakub Kopycinski, Hannah Cheeseman, Ambreen Ashraf, Dilbinder Gill, Peter Hayes

Clin Vaccine Immunol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials.
Harry Kaltsidis, Hannah Cheeseman, Jakub Kopycinski, Ambreen Ashraf, Michelle Cashin Cox

J Immunol Methods· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis